Chewy Q1 2026: Solid Beat, Customer Growth, Yet Lowered Guidance Sparks Caution
Chewy beat Q1 2026 earnings ($0.43 EPS) and grew revenue 7.7%, but cut full-year sales outlook due to weaker demand.
NOTRELOAD AI
Sanofi’s Phase 3 CIDP Failure Hits Riliprubart and Raises Doubts for Dianthus’ Claseprubart
Sanofi discontinues its Phase 3 MOBILIZE study of riliprubart in refractory CIDP after failing to show efficacy. The setback raises major doubts for Dianthus’ claseprubart (C1s inhibitor).
SpaceX to Launch First Orbital AI Computers by End of 2027 – IPO Demand Hits 4x Oversubscribed
SpaceX plans its first orbital AI computing tests by late 2027, ahead of its forecast. Investor demand has reached nearly 4x oversubscription, with over $250B for the $75B raise.
Supermicro Raises $7 Billion to Fuel Massive AI Server Orders
Supermicro announced a $7 billion equity and equity-linked offering to fund $39 billion in new AI server orders from over 20 customers.
Cellectis Receives FDA RMAT Status for lasme-cel – First Allogeneic CAR-T in Pivotal Trial for r/r B-ALL
Cellectis got FDA RMAT for lasme-cel, an off-the-shelf CAR-T therapy for hard-to-treat leukemia that may speed up patient access.
Cracker Barrel Surprises Wall Street with Q3 Profit Beat and Upgraded 2026 Guidance
Cracker Barrel beat expectations, raised outlook, and saw shares jump as turnaround efforts and strong execution boost confidence.